Cronos sells Whistler Medical shares to Aurora Cannabis
The marijuana producer sells its stake in Whistler Medical Marijuana to rival Aurora.
Why is Cronos selling Whistler shares to Aurora?
Cronos has sold its shares in Whistler Medical, a medical marijuana company that produces 18 strains of pot and also sells CBD oil, to capitalise on the pot boom across the US and Canada. As the drug is legalised across much of North America, the growth in cannabis has led many marijuana companies to consolidate as a result.
In this strategic deal, Aurora will pay Cronos C$175 million for the stake in Whistler Medical. In return for the stake, Cronos will receive Aurora stock worth C$26.6 million dollars. Cronos will also receive an extra C$7.6 million shares based on the achievement of certain milestones after the acquisition.
Mike Gorenstein, chief executive officer (CEO), of Cronos, thanked Whistler for their partnership after selling the shares.
‘We'd like to thank and congratulate Whistler for their partnership over the past two years,’ said Gorenstein.
‘Whistler's commitment to creating high-quality products and establishing a premium brand has generated value for consumers and investors alike. We are proud to have been part of their growth and look forward to their progress through this venture,’ added Gorenstein.
Aurora CEO, Terry Booth, spoke about the expansion efforts the company wants to implement with its purchase of Whistler.
‘Applying certain of our best practices to the Whistler cultivation protocols, we anticipate an increase in capacity of the Pemberton facility beyond the stated 5,000 kg annual production target,’ said Booth in a statement.
What’s next for Cronos stock?
Cronos stock rose briefly before falling after Aurora acquired its shares of Whistler Medical. Though some investors say marijuana is a good investment and are bullish on the commodity, there is also concern about an oversaturation in the market. Cronos and Aurora hope that this consolidation will encourage investors to continue to invest in marijuana.
This information has been prepared by IG, a trading name of IG Markets Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer and quarterly summary.
Seize a share opportunity today
Go long or short on thousands of international stocks.
- Increase your market exposure with leverage
- Get spreads from just 0.1% on major global shares
- Trade CFDs straight into order books with direct market access
Live prices on most popular markets